Target intelligence / Profile preview

Lipophilic small molecules

01

Overview

Lipophilic small molecules are chemical entities characterized by their ability to dissolve in lipids, fats, or non-polar solvents rather than water. This property is quantified using the partition coefficient (logP), with lipophilic molecules generally having a logP greater than 2. Lipophilicity profoundly affects a molecule’s pharmacokinetic profile—this includes absorption (increased ability to cross biological membranes), distribution (accumulation in fatty tissues), metabolism, and excretion. Many drugs are designed to be lipophilic to optimize oral absorption and tissue penetration, but excessive lipophilicity can lead to poor solubility and bioavailability as well as off-target accumulation. Lipophilic molecules can nonspecifically interact with biological materials (e.g., absorption into device polymers like PDMS), complicating drug formulation and bioanalytical measurement. Key note: There is no "Lipophilic small molecules" receptor or canonical target. The phrase is a property class and refers broadly to any small molecule possessing significant lipophilicity, but not to a discrete biological entity. Therefore, it is not appropriate to treat "lipophilic small molecules" as a target for structured biomedical annotation.

Other names
Lipophilic compoundsFat-soluble small moleculesHydrophobic small molecules
02

Safety considerations

Excessive lipophilicity can lead to poor solubility and bioavailabilityOff-target accumulationNonspecific interactions with biological materials or device polymers

Beyond the preview

Go deeper on Lipophilic small molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipophilic small molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call